31.25 USD
↗ 0.04 (0.13%)PRE MARKET (AS OF 07:25 PM EDT)
Staar Surgical Co
STAANASDAQ • USD
Market: OPEN
Shares of Staar Surgical Co (STAA) are trading at $31.25. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. This is driven by a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, STAA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 25, 2026.
Open?$28.94
High?$31.27
Low?$27.07
Prev. Close?$31.21
Volume?552.3K
Avg. Volume?872.5K
VWAP?$30.65
Rel. Volume?0.63x
Bid / Ask
Bid?$26.55 × 100
Ask?$35.34 × 100
Spread?$8.79
Midpoint?$30.95
Valuation & Ratios
Market Cap?1.6B
Shares Out?49.8M
Float?29.9M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?4.41
EPS?-$0.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
Address
1911 WALKER AVE
MONROVIA, CA 91016
Phone: (626) 303-7902
MONROVIA, CA 91016
Phone: (626) 303-7902
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?85
Short Sent.?45
Piotroski F-Score?5/9Mixed
Altman Z-Score?10.12Safe
Confidence?61%Moderate
Short InterestHigh
Short % of Float?16.91%High
Short Interest?5.1M
Days to Cover?9.1
Free Float29.9M
Avg Daily Volume558.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?5.12Strong
Quick Ratio?4.31Strong
Cash Ratio?2.16Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?4.41FAIR▾
Peers100
S&P41
P/S?5.35FAIR▾
Peers100
S&P27
P/FCF?N/A▾
EV/EBITDA?-156.6CHEAP▾
S&P97
EV/Sales?4.90FAIR▾
Peers100
S&P37
Returns & Efficiency
ROE?-6.0%WEAK▾
S&P10
ROA?-4.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-54986000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day